Advertisement
Screener

FibroBiologics, Inc. (FBLG) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

FibroBiologics, Inc. (FBLG) Return on Tangible Equity

  • 2026-06-30: Return Tang Equity -391.26%.
  • 2026-03-31: Return Tang Equity -718.46%.
  • 2025-12-31: Return Tang Equity -302.89%.
  • 2025-09-30: Return Tang Equity -14800.80%.

Complete source-backed return tang equity history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang Equity
2026-06-30-391.26%
2026-03-31-718.46%
2025-12-31-302.89%
2025-09-30-14800.80%
2025-06-30-1537.56%
2025-03-31-326.26%
2024-12-31-408.08%
2024-09-30-649.58%
2024-06-30815.75%
2024-03-31583.23%
2023-12-31-1315.64%

Annual Return Tang Equity

DateReturn Tang Equity
2025-12-31-302.89%
2024-12-31-408.08%
2023-12-31-1315.64%
2022-12-31128.15%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
Imunon, Inc. (IMNN)United States$0.008B-0.56
SOLIGENIX, INC. (SNGX)United States$0.008B
Medicus Pharma Ltd. (MDCX)$0.010B
Azitra, Inc. (AZTR)United States$0.010B-0.81
EXICURE, INC. (XCUR)United States$0.008B-1.54
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65